Cohort 
2019

Sebastian Moguilner, MS

Neuroscientist

We need to encourage creative solutions to provide new approaches to find early and reliable biomarkers.

Current Work

Sebastian is researching new neuroimaging biomarkers and machine learning applications for artificial intelligence assisted diagnosis.

Personal Hero

Alan Turing

Words of Strength

Technical skills

Vision

To reduce the scale and impact of dementia, Sebastian believes we need to encourage creative solutions to provide new approaches to find early and reliable biomarkers.

Strategy

Sebastian is developing diagnostic software based on artificial intelligence to enhance our current diagnostic protocols.

Impact

As an Atlantic Fellow, Sebastian gained a deeper understanding of the socioeconomic status risk factors of dementia. This allowed him to complement my technical background.

Motivation

By 2050, the number of people with dementia in Argentina is predicted to increase four-fold. Novel approaches are needed to provide early biomarkers. Artificial intelligence can be used as a tool to enhance our current diagnostic protocols.

Education & Experience

Sebastian received his physics and master's in medical physics degrees from the Balseiro Institute, Bariloche, Argentina. He is currently finishing his Ph.D. studies in the School of Nuclear Medicine Foundation, Mendoza, Argentina.

School of Nuclear Medicine Foundation, Mendoza, Argentina
PhD (in process)
Balseiro Institute, Bariloche, Argentina
Medical Physics
MS
Balseiro Institute, Bariloche, Argentina
Physics
BS